Infections in Hospitalized Cancer Patients

Amanda Delgado, Achuta Kumar Guddati

Research output: Contribution to journalArticlepeer-review

Abstract

Cancer patients are at an increased risk of developing infections that are primarily treatment-driven but may also be malignancy-driven.While cancer treatments such as chemotherapy, radiotherapy, andsurgery have been known to improve malignancy morbidity and mortality,they also have the potential to weaken immune defenses andinduce periods of severe cytopenia. These adverse effects pave theway for opportunistic infections to complicate a hospitalized cancerpatient’s clinical course. Understanding the risk each patient inherentlyhas for developing a bacterial, fungal, or viral infection is criticalto choosing the correct prophylactic treatment in conjunction withtheir scheduled cancer therapy. This review discusses the most commontypes of infections found in hospitalized cancer patients as wellas the current guidelines for prophylactic and antimicrobial treatmentin cancer patients. In addition, it describes the interaction betweenantibiotics and cancer therapies for consideration when treating infectionin a cancer patient

Original languageEnglish (US)
Pages (from-to)195-205
Number of pages11
JournalWorld Journal of Oncology
Volume12
Issue number6
DOIs
StatePublished - 2021

Keywords

  • Cancer
  • Infection
  • Morbidity
  • Mortality

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Infections in Hospitalized Cancer Patients'. Together they form a unique fingerprint.

Cite this